Education
About Us
Working with TipRanks
Follow Us
Cytori Cell Research Institute, Inc. (JP:3750)
:3750
3750 Stock Chart & Stats
¥829.00
-¥5.00(-0.59%)
At close: 4:00 PM EST
¥829.00
-¥5.00(-0.59%)
Day’s Range― - ―
52-Week Range¥642.00 - ¥990.00
Previous CloseN/A
Volume9.00K
Average Volume (3M)5.90K
Market Cap
¥7.31B
Enterprise Value¥6.87B
Total Cash (Recent Filing)¥369.76M
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)55.1
Beta0.44
Next Earnings
Nov 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 30, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)7.82
Shares Outstanding8,929,419
10 Day Avg. Volume2,510
30 Day Avg. Volume5,903
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)11.36
Price to Sales (P/S)58.59
P/FCF Ratio-7.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
3750 FAQ
What was Cytori Cell Research Institute, Inc.’s price range in the past 12 months?
Cytori Cell Research Institute, Inc. lowest stock price was ¥642.00 and its highest was ¥990.00 in the past 12 months.
What is Cytori Cell Research Institute, Inc.’s market cap?
Cytori Cell Research Institute, Inc.’s market cap is ¥7.31B.
When is Cytori Cell Research Institute, Inc.’s upcoming earnings report date?
Cytori Cell Research Institute, Inc.’s upcoming earnings report date is Nov 07, 2025 which is in 5 days.
How were Cytori Cell Research Institute, Inc.’s earnings last quarter?
Cytori Cell Research Institute, Inc. released its earnings results on Aug 14, 2025. The company reported ¥7.82 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.82.
Is Cytori Cell Research Institute, Inc. overvalued?
According to Wall Street analysts Cytori Cell Research Institute, Inc.’s price is currently Overvalued.
Does Cytori Cell Research Institute, Inc. pay dividends?
Cytori Cell Research Institute, Inc. pays a Annually dividend of ¥10 which represents an annual dividend yield of N/A. See more information on Cytori Cell Research Institute, Inc. dividends here
What is Cytori Cell Research Institute, Inc.’s EPS estimate?
Cytori Cell Research Institute, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cytori Cell Research Institute, Inc. have?
Cytori Cell Research Institute, Inc. has 8,929,419 shares outstanding.
What happened to Cytori Cell Research Institute, Inc.’s price movement after its last earnings report?
Cytori Cell Research Institute, Inc. reported an EPS of ¥7.82 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cytori Cell Research Institute, Inc.?
Currently, no hedge funds are holding shares in JP:3750
Company Description
Cytori Cell Research Institute, Inc.
Cytori Cell Research Institute, Inc. is a biotechnology company specializing in regenerative medicine and cell therapy. The company focuses on developing innovative solutions for tissue repair and regeneration, leveraging its proprietary technologies that utilize adipose-derived stem cells. Cytori operates primarily within the healthcare sector, aiming to address unmet medical needs, particularly in areas such as cardiovascular diseases, orthopedic injuries, and wound healing.
Technical Analysis
D.Western Therapeutics Institute
―
OncoTherapy Science
―
Ribomic, Inc.
―
Delta-Fly Pharma, Inc.
―
Kringle Pharma, Inc.
―